European Archives - Page 1048 of 1136 - European Medical Journal

Transforming Growth Factor Beta-Based Therapies, a Potential Modulator of the Immune Response in Type 1 Diabetes?

Immunobiological interventions are proving to be an exciting new area for mobilising the immune response towards certain tumours.

EMJ Diabetes 3.1 2015

Hello and a very warm welcome to European Medical Journal Diabetes. This is the last edition of what has been a busy year for the field, so we have made…

EMJ

Fallopian Tube Discovery Could Boost IVF

NOBEL PRIZE-WINNING technology has helped to reveal the process by which fertilisation occurs. Fertilisation normally happens as the oocyte is moved…

EMJ

Ovarian Transplants Proven Safe and Effective in Cancer Patients

YOUNG women who are diagnosed with ovarian cancer now have the opportunity to conceive later in life, thanks to safe and effective ovarian transplants.

EMJ

Blackouts and near Drownings May Signal Sudden Death Risk

Rustenburg, South Africa 25 October 2015: Blackouts and near drowning events may signal an increased risk of sudden death, reveals research presented at…

EMJ

Sniffing and Gasping Can Prevent Fainting

Vienna, Austria – 17 October 2015: Sniffing and gasping can prevent fainting, reveals research presented today at Acute Cardiovascular Care 2015…

EMJ

Exercise Does the Heart Good, Especially in Patients with Type 2 Diabetes

HIGH intensity intermittent exercise training has been shown to reverse heart abnormalities, improve heart structure, and benefit diabetes control…

EMJ

Novel Transplant Technique Frees Type 1 Diabetes Patient from Insulin Therapy

‘Cured!’ may be the statement on the lips of Type 1 diabetes patients in the next few decades, following a recent announcement by the…

EMJ

Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)

At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…

EMJ

Immunotherapy: Targeting tumour heterogeneity

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…